Nalaganje...
Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses
Major progress in cancer immunotherapies have been obtained by the use of tumor targeting strategies, in particular with the development of bi-functional fusion proteins such as ImmTacs or BiTes, which engage effector T cells for targeted elimination of tumor cells. Given the significance of invaria...
Shranjeno v:
| izdano v: | Front Immunol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5672503/ https://ncbi.nlm.nih.gov/pubmed/29163493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.01417 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|